Home testing and home sampling are not one and the same and it is important for potential users and their providers to understand the key differences between the two. HIV home testing is coming. Not right now, because none of the non-clinical commercial testing kits
Absence of evidence is not evidence of absence. Does the PARTNER study signal the death of condoms or should we curb our enthusiasm, and carry on pretending we use them? The preliminary results of the PARTNER study were one of the most talked about data
HIV home testing may appeal to some people unaware of their HIV status and not prepared to visit a GUM clinic. However, home testing could lead to an increased attrition in the HIV cascade of care and treatment, as well as threaten sexual health and
Limited community awareness, late and superficial institutional support, and cost-effectiveness issues paint a bleak future for Pre-Exposure Prophylaxis in the UK. On the opening day of the TasP PrEP Evidence Summit organised by IAPAC, Lord Fowler expressed his bemusement at the US attitude towards clean
The TasP PrEP evidence Summit organised by the International Association of Providers of AIDS Care (IAPAC) opens in London with a welcomed tone that departs from the usual HIV Grand Masses. There is something in the annual IAPAC conference in London that is not often